Efficacy of Fractional CO2 Laser Therapy in Improving Symptoms and Quality of Life in Women with Refractory Vulvar Lichen Sclerosus: A Prospective Observational Study
Life · 18.12.2024 · 14 (12) · 1678
DOI: 10.3390/life14121678 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life, online erschienen am 18.12.2024. Verfasst von Ana Gil-Villalba und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Hospital Universitario Nuestra Señora de Candelaria, 38010 Santa Cruz de Tenerife, Spain. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lichen sclerosus (LS) is a chronic inflammatory condition predominantly affecting the anogenital region of postmenopausal women. It is associated with considerable aesthetic and functional impairments and an increased risk of squamous cell carcinoma. While high-potency topical corticosteroids remain the cornerstone of treatment, therapeutic options for patients with refractory LS are scarce. Fractional CO2 laser therapy has emerged as a potential second-line intervention aiming to mitigate symptoms and improve quality of life. This prospective observational study investigated the short-term efficacy and safety of fractional CO2 laser therapy in 75 women with refractory LS who underwent four treatment sessions between January 2022 and February 2024. Sixty-nine patients completed the protocol, demonstrating significant reductions in key symptoms, including pruritus (VAS score from 7.53 ± 3.02 to 4.08 ± 3.07), pain (5.83 ± 3.84 to 2.42 ± 2.85), and dyspareunia (8.26 ± 2.82 to 6.34 ± 3.30). Quality of life, sexual function, and psychological well-being also improved, as evidenced by reductions in Dermatology Life Quality Index (DLQI) scores (10.72 ± 7.25 to 5.94 ± 5.16), enhancements in sexual function (FSFI scores from 10.48 ± 8.46 to 15.52 ± 9.59), and decreased depression severity (BDI scores from 16.66 ± 12.64 to 5.94 ± 5.16). Importantly, no adverse effects were reported during the study period. Although these findings highlight the potential of fractional CO2 laser therapy as a safe and effective adjunct for refractory LS, it is essential to acknowledge the study’s limitations, particularly the relatively short follow-up period. Longer-term studies are warranted to confirm sustained benefits and to evaluate the broader applicability of this approach.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dermatology Department, Hospital Universitario Nuestra Señora de Candelaria, 38010 Santa Cruz de Tenerife, Spain.
- Instituto Biosanitario de Granada, Ibs, 18012 Granada, Spain.
- Dermatology Department, Hospital Universitario San Cecilio, 18016 Granada, Spain.
ORCID-Profile: Ricardo Ruiz-Villaverde
Zitieren
APA
Gil-Villalba, A., Ayén-Rodríguez, Á., Naranjo-Díaz, M. J., Linares-González, L., & Ruiz-Villaverde, R. (2024). Efficacy of Fractional CO2 Laser Therapy in Improving Symptoms and Quality of Life in Women with Refractory Vulvar Lichen Sclerosus: A Prospective Observational Study. Life, 14(12), 1678. https://doi.org/10.3390/life14121678
Vancouver
Gil-Villalba A, Ayén-Rodríguez Á, Naranjo-Díaz MJ, Linares-González L, Ruiz-Villaverde R. Efficacy of Fractional CO2 Laser Therapy in Improving Symptoms and Quality of Life in Women with Refractory Vulvar Lichen Sclerosus: A Prospective Observational Study. Life. 2024;14(12):1678. doi:10.3390/life14121678
BibTeX
@article{GilVillalba2024,
author = {Gil-Villalba, Ana and Ayén-Rodríguez, Ángela and Naranjo-Díaz, María José and Linares-González, Laura and Ruiz-Villaverde, Ricardo},
title = {Efficacy of Fractional CO2 Laser Therapy in Improving Symptoms and Quality of Life in Women with Refractory Vulvar Lichen Sclerosus: A Prospective Observational Study},
journal = {Life},
year = {2024},
volume = {14},
number = {12},
pages = {1678},
doi = {10.3390/life14121678}
}
EUVIMED